First quarter 2021 device financing reached $2.8bn, a sharp decline from the fourth quarter of 2020’s $4.2bn. The follow-on public offering (FOPO) category made up the most, accounting for $780m, or 28%, of the first-quarter total, followed by VC financings, which brought in an aggregate $736m, or 27% of the first-quarter financing dollars.
Financing Quarterly Statistics: Q1 Highlights Include 3 Medtech And 7 IVD IPOs
A Look At Financing Activity Across Medical Device And In Vitro Diagnostics Industries, January-March 2021
To open the year, medical device company fundraising totaled $2.8bn; while in vitro diagnostic firms and research tools players raised $7bn.
